drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy

Other Services
Reprints / E-Prints
Submit News
White Papers

Retail News Breaks Archives

Week of   

Week of Mon, Dec 17th, 2012

First-quarter earnings drop at Walgreens

Citing the impact of various items, including a reporting change for its partnership with Alliance Boots, Walgreen Co. saw net income sink for its fiscal 2013 first quarter, coming in well below Wall Street's forecast.

Walgreens work-site centers accredited as 'medical homes'

Half of the primary care work-site health centers managed by Walgreens Employer Solutions Group have received Medical Home accreditation, Walgreen Co. and the Accreditation Association for Ambulatory Health Care (AAAHC) announced.

Rite Aid turns profit in third quarter

Rite Aid Corp. jumped a key financial hurdle by reporting net income for its fiscal 2013 third quarter, marking the company's first quarterly profit in over five years.

NACDS promotes finance exec with CFO's retirement

David Fitzsimmons has been promoted to senior vice president of finance and administration at the National Association of Chain Drug Stores.

Pharmacists seen as 'sensible solution' for health care delivery

A dearth of primary care doctors and high medical costs is shining a spotlight on pharmacists, among other providers, as a "sensible solution" for affordable health care delivery, according to a New York Times editorial.

Walgreens' Crawford to join Allstate board

Kermit Crawford, president of pharmacy, health and wellness at Walgreen Co., has been elected to the board of directors at Allstate Corp.

NACDS: Senator advocates for MTM coverage

The National Association of Chain Drug Stores is hailing Sen. Kay Hagan (D., N.C.) for her leadership on behalf of pharmacy patient care, in particular medication therapy management (MTM).

Awareness remains hurdle with loyalty programs

Chain drug stores are on the leading edge in using loyalty cards to win and keep pharmacy customers, yet customer awareness of such programs could be greater, a study by Boehringer Ingelheim Pharmaceuticals reveals.